Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Review

Incidence of drug-related adverse events related to the use of high-alert drugs: a systematic review of randomized controlled trials.

Menezes MS, Doria GAA, Valença-Feitosa F, et al. Incidence of drug-related adverse events related to the use of high-alert drugs: a systematic review of randomized controlled trials. Explor Res Clin Social Pharm. 2024;14:100435. doi:10.1016/j.rcsop.2024.100435.

Save
Print
June 19, 2024
Menezes MS, Doria GAA, Valença-Feitosa F, et al. Explor Res Clin Social Pharm. 2024;14:100435.
View more articles from the same authors.

High-risk medications are classified as such due to their narrow therapeutic range and potential for serious adverse drug events (ADE). This review analyzes the results of randomized clinical trials to identify effective interventions to reduce ADE related to high-risk medications in hospitals. The most cited medications were warfarin, cyclophosphamide, and cyclosporine. The most common intervention was developing protocols for safe use.

Save
Print
Cite
Citation

Menezes MS, Doria GAA, Valença-Feitosa F, et al. Incidence of drug-related adverse events related to the use of high-alert drugs: a systematic review of randomized controlled trials. Explor Res Clin Social Pharm. 2024;14:100435. doi:10.1016/j.rcsop.2024.100435.

Related Resources From the Same Author(s)
Related Resources